Annual CAPEX
$62.54 M
+$21.74 M+53.28%
December 31, 2024
Summary
- As of March 9, 2025, DNA annual capital expenditures is $62.54 million, with the most recent change of +$21.74 million (+53.28%) on December 31, 2024.
- During the last 3 years, DNA annual CAPEX has risen by +$6.02 million (+10.65%).
- DNA annual CAPEX is now at all-time high.
Performance
DNA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$13.71 M
-$1.38 M-9.14%
December 31, 2024
Summary
- As of March 9, 2025, DNA quarterly capital expenditures is $13.71 million, with the most recent change of -$1.38 million (-9.14%) on December 31, 2024.
- Over the past year, DNA quarterly CAPEX has dropped by -$1.38 million (-9.14%).
- DNA quarterly CAPEX is now -49.28% below its all-time high of $27.03 million, reached on June 30, 2024.
Performance
DNA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$62.54 M
+$10.26 M+19.63%
December 31, 2024
Summary
- As of March 9, 2025, DNA TTM capital expenditures is $62.54 million, with the most recent change of +$10.26 million (+19.63%) on December 31, 2024.
- Over the past year, DNA TTM CAPEX has increased by +$10.26 million (+19.63%).
- DNA TTM CAPEX is now -13.25% below its all-time high of $72.09 million, reached on June 30, 2023.
Performance
DNA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
DNA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +53.3% | -9.1% | +19.6% |
| 3 y3 years | +10.7% | -46.5% | +19.6% |
| 5 y5 years | +181.5% | - | - |
DNA CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +53.3% | -49.3% | +297.9% | -13.3% | +163.8% |
| 5 y | 5-year | at high | +181.5% | -49.3% | +297.9% | -13.3% | +185.1% |
| alltime | all time | at high | +181.5% | -49.3% | +297.9% | -13.3% | +185.1% |
Ginkgo Bioworks Holdings CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $62.54 M(+53.3%) | $13.71 M(-9.1%) | $62.54 M(+19.6%) |
| Sep 2024 | - | $15.09 M(-44.2%) | $52.28 M(+25.8%) |
| Jun 2024 | - | $27.03 M(+302.9%) | $41.57 M(+48.1%) |
| Mar 2024 | - | $6.71 M(+94.7%) | $28.07 M(-31.2%) |
| Dec 2023 | $40.80 M(-21.9%) | $3.45 M(-21.3%) | $40.80 M(-35.2%) |
| Sep 2023 | - | $4.38 M(-67.6%) | $63.00 M(-12.6%) |
| Jun 2023 | - | $13.53 M(-30.4%) | $72.09 M(+5.8%) |
| Mar 2023 | - | $19.44 M(-24.2%) | $68.13 M(+30.3%) |
| Dec 2022 | $52.27 M | $25.64 M(+90.3%) | $52.27 M(+64.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $13.47 M(+40.7%) | $31.74 M(+33.9%) |
| Jun 2022 | - | $9.57 M(+167.4%) | $23.70 M(-37.9%) |
| Mar 2022 | - | $3.58 M(-30.0%) | $38.17 M(-32.5%) |
| Dec 2021 | $56.52 M(-2.2%) | $5.11 M(-6.0%) | $56.52 M(+9.9%) |
| Sep 2021 | - | $5.44 M(-77.4%) | $51.41 M(+11.8%) |
| Jun 2021 | - | $24.03 M(+9.6%) | $45.97 M(+109.6%) |
| Mar 2021 | - | $21.93 M | $21.93 M |
| Dec 2020 | $57.82 M(+160.2%) | - | - |
| Dec 2019 | $22.22 M | - | - |
FAQ
- What is Ginkgo Bioworks Holdings annual capital expenditures?
- What is the all time high annual CAPEX for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual CAPEX year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly CAPEX year-on-year change?
- What is Ginkgo Bioworks Holdings TTM capital expenditures?
- What is the all time high TTM CAPEX for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings TTM CAPEX year-on-year change?
What is Ginkgo Bioworks Holdings annual capital expenditures?
The current annual CAPEX of DNA is $62.54 M
What is the all time high annual CAPEX for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual capital expenditures is $62.54 M
What is Ginkgo Bioworks Holdings annual CAPEX year-on-year change?
Over the past year, DNA annual capital expenditures has changed by +$21.74 M (+53.28%)
What is Ginkgo Bioworks Holdings quarterly capital expenditures?
The current quarterly CAPEX of DNA is $13.71 M
What is the all time high quarterly CAPEX for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly capital expenditures is $27.03 M
What is Ginkgo Bioworks Holdings quarterly CAPEX year-on-year change?
Over the past year, DNA quarterly capital expenditures has changed by -$1.38 M (-9.14%)
What is Ginkgo Bioworks Holdings TTM capital expenditures?
The current TTM CAPEX of DNA is $62.54 M
What is the all time high TTM CAPEX for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high TTM capital expenditures is $72.09 M
What is Ginkgo Bioworks Holdings TTM CAPEX year-on-year change?
Over the past year, DNA TTM capital expenditures has changed by +$10.26 M (+19.63%)